Entity Common Stock, Shares Outstanding of NeuBase Therapeutics, Inc. from Q3 2011 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NeuBase Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q3 2011 to Q3 2023.
  • NeuBase Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 06 Nov 2023 was 3,729,206.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

NeuBase Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 3,729,206 06 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 33,810,356 +1,551,699 +4.8% 26 May 2023 10-QT 05 Jun 2023 2022 Q1
Q1 2023 33,810,356 +1,551,699 +4.8% 08 May 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 33,008,657 +282,723 +0.86% 16 Dec 2022 10-K 21 Dec 2022 2022 FY
Q2 2022 32,258,657 -458,170 -1.4% 05 Aug 2022 10-Q 11 Aug 2022 2022 Q3
Q1 2022 32,258,657 -458,170 -1.4% 06 May 2022 10-Q 12 May 2022 2022 Q2
Q4 2021 32,725,934 +9,548,343 +41% 15 Dec 2021 10-K 23 Dec 2021 2021 FY
Q2 2021 32,716,827 +9,594,474 +41% 11 Aug 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 32,716,827 +15,636,202 +92% 12 May 2021 10-Q 14 May 2021 2021 Q2
Q4 2020 23,177,591 +6,099,718 +36% 21 Dec 2020 10-K 23 Dec 2020 2020 FY
Q2 2020 23,122,353 +6,051,980 +35% 12 Aug 2020 10-Q 13 Aug 2020 2020 Q3
Q1 2020 17,080,625 +14,251,377 +504% 25 Mar 2020 10-Q 26 Mar 2020 2020 Q1
Q4 2019 17,077,873 -39,388,555 -70% 07 Jan 2020 10-K 10 Jan 2020 2019 FY
Q2 2019 17,070,373 -39,396,055 -70% 14 Aug 2019 10-Q 14 Aug 2019 2019 Q3
Q1 2019 2,829,248 -53,637,180 -95% 13 May 2019 10-Q 15 May 2019 2019 Q2
Q4 2018 56,466,428 +270,000 +0.48% 02 Jan 2019 10-K 03 Jan 2019 2018 FY
Q2 2018 56,466,428 +255,000 +0.45% 14 Aug 2018 10-Q 14 Aug 2018 2018 Q3
Q1 2018 56,466,428 +255,000 +0.45% 15 May 2018 10-Q 15 May 2018 2018 Q2
Q4 2017 56,196,428 +20,235,032 +56% 13 Dec 2017 10-K 15 Dec 2017 2017 FY
Q2 2017 56,211,428 +24,107,459 +75% 07 Aug 2017 10-Q 08 Aug 2017 2017 Q3
Q1 2017 56,211,428 +24,714,559 +78% 09 May 2017 10-Q 11 May 2017 2017 Q2
Q4 2016 35,961,396 +5,630,087 +19% 20 Dec 2016 10-K 22 Dec 2016 2016 FY
Q2 2016 32,103,969 +1,772,660 +5.8% 08 Aug 2016 10-Q 09 Aug 2016 2016 Q3
Q1 2016 31,496,869 +1,165,560 +3.8% 08 May 2016 10-Q 10 May 2016 2016 Q2
Q4 2015 30,331,309 +5,071,119 +20% 14 Dec 2015 10-K 14 Dec 2015 2015 FY
Q2 2015 30,331,309 06 Aug 2015 10-Q 06 Aug 2015 2015 Q3
Q1 2015 30,331,309 +6,713,526 +28% 11 May 2015 10-Q 11 May 2015 2015 Q2
Q4 2014 25,260,190 +5,290,144 +26% 22 Dec 2014 10-K 22 Dec 2014 2014 FY
Q3 2014 24,862,645 18 Aug 2014 10-Q 18 Aug 2014 2014 Q3
Q1 2014 23,617,783 -26,083,705 -52% 12 May 2014 10-Q 13 May 2014 2014 Q2
Q4 2013 19,970,046 -27,720,056 -58% 27 Dec 2013 10-K 27 Dec 2013 2013 FY
Q2 2013 19,677,792 -27,466,461 -58% 30 Jun 2013 10-Q 13 Aug 2013 2013 Q3
Q1 2013 49,701,488 +7,986,237 +19% 31 Mar 2013 10-Q 14 May 2013 2013 Q2
Q4 2012 47,690,102 0 0% 31 Dec 2012 10-Q 19 Feb 2013 2013 Q1
Q3 2012 15,752,896 -23,949,684 -60% 30 Sep 2012 10-Q 13 Aug 2013 2013 Q3
Q2 2012 47,144,253 30 Jun 2012 10-Q 07 Aug 2012 2012 Q3
Q1 2012 41,715,251 11 May 2012 10-Q 11 May 2012 2012 Q2
Q4 2011 47,690,102 03 Jan 2012 10-K 09 Jan 2013 2012 FY
Q3 2011 39,702,580 30 Sep 2011 10-K 09 Jan 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.